Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type (Instruments and Reagents and Kits), By Technology (Helicase Dependent Amplification (HAD), Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence Based Amplification (NASBA), Transcription Medicated Amplification (TMA), Single Primer Isothermal Amplification (SPIA), and Loop-mediated Isothermal Amplification (LAMP)), By Application (Infectious Disease Diagnostics, Blood Screening, and Others), By End User (Academic and Research Institutes, Diagnostic Laboratories, and Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Isothermal nucleic acid amplification technologies have applications in the field of recombinant DNA and molecular biology techniques. These techniques are used in the detection and analysis of small quantity of nucleic acids. Polymerase chain reaction is based on isothermal nucleic acid amplification technology. The polymerase chain reaction (PCR) is most widely used method for DNA amplification. Polymerase chain reaction (PCR) is used for the detection and identification of infectious diseases, genetic disorders, and for research purposes. PCR consists of thermocycling machine that facilitates separation and amplification of DNA strands. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature. Various isothermal amplification techniques have been developed as alternatives to polymerase chain reaction (PCR).
Isothermal amplification chemistry has also been used to diagnostics with great success and is utilized in several commercial molecular diagnostic platforms, serving large testing centers and point-of-care markets. The advantage of these methods is that the nucleic acids amplification can be carried out at constant temperature, unlike PCR that requires cyclic temperature changes. Moreover, isothermal amplification can be conducted directly in living cells. The thermodynamics process in which the temperature of the whole system remains constant over a period of time is called isothermal process. Thus, the constant temperature of any system makes the process an isothermal process. For example, melting of ice at zero degree is an example of an isothermal process.
Market Dynamics
Increasing adoption of organic growth strategies such as approvals from healthcare regulatory authorities for innovative technologies by key market players, in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in September 2020, Abbott, a healthcare company that helps people live more fully at all stages of life, received approval from Health Canada for the ID NOW rapid COVID-19 testing device for usage in Canada.
Key features of the study:
This report provides in-depth analysis of the global isothermal nucleic acid amplification technology (INAAT) market size (US$ 2,315.7 Million), and compound annual growth rate (CAGR 4%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global isothermal nucleic acid amplification technology (INAAT) market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
Global isothermal nucleic acid amplification technology (INAAT) market report caters to various stakeholders in this industry including investors, product manufacturers, distributors, and suppliers for isothermal nucleic acid amplification technology (INAAT) market, research and consulting firms, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global isothermal nucleic acid amplification technology (INAAT) market
Detailed Segmentation:
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type:
Instruments
Reagents and Kits
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application:
Infectious Disease Diagnostics
Blood Screening
Others
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology:
Helicase Dependent Amplification (HAD)
Nicking Enzyme Amplification Reaction (NEAR)
Nucleic Acid Sequence Based Amplification (NASBA)
Transcription Medicated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Loop-mediated Isothermal Amplification (LAMP)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End User:
Academic and Research Institutes
Diagnostic Laboratories
Others
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Region:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country:
GCC
Israel
Rest of Middle East
Africa
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Alere Inc.,*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Becton, Dickinson & Company
BioHelix Corporation
BioMerieux Biotechnology Company
Hologic Gene-Probe
QIAGEN Company
Thermo Fisher Scientific, Inc.
Lucigen Corporation
Quidel Corporation
NuGEN
“*” marked represents similar segmentation in other categories in the respective section.
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Technology
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis